These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 15516806)

  • 1. [Physiological function of blood-brain barrier transporters as the CNS supporting and protecting system].
    Ohtsuki S
    Yakugaku Zasshi; 2004 Nov; 124(11):791-802. PubMed ID: 15516806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system.
    Ohtsuki S
    Biol Pharm Bull; 2004 Oct; 27(10):1489-96. PubMed ID: 15467183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanisms of drug influx and efflux transport at the blood-brain barrier].
    Ohtsuki S; Hori S; Terasaki T
    Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):55-64. PubMed ID: 12843573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The l-isomer-selective transport of aspartic acid is mediated by ASCT2 at the blood-brain barrier.
    Tetsuka K; Takanaga H; Ohtsuki S; Hosoya K; Terasaki T
    J Neurochem; 2003 Nov; 87(4):891-901. PubMed ID: 14622120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain.
    Ohtsuki S; Asaba H; Takanaga H; Deguchi T; Hosoya K; Otagiri M; Terasaki T
    J Neurochem; 2002 Oct; 83(1):57-66. PubMed ID: 12358729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GAT2/BGT-1 as a system responsible for the transport of gamma-aminobutyric acid at the mouse blood-brain barrier.
    Takanaga H; Ohtsuki S; Hosoya Ki ; Terasaki T
    J Cereb Blood Flow Metab; 2001 Oct; 21(10):1232-9. PubMed ID: 11598501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Membrane Transporters and Their Regulatory Mechanisms at the Brain and Retinal Barriers to Establish Therapies for Refractory Central Nervous System Diseases].
    Akanuma SI
    Yakugaku Zasshi; 2020; 140(10):1235-1242. PubMed ID: 32999202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepiandrosterone sulfate, across the blood-brain barrier in mice.
    Miyajima M; Kusuhara H; Fujishima M; Adachi Y; Sugiyama Y
    Drug Metab Dispos; 2011 May; 39(5):814-9. PubMed ID: 21325432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier transporters and response to CNS-active drugs.
    Urquhart BL; Kim RB
    Eur J Clin Pharmacol; 2009 Nov; 65(11):1063-70. PubMed ID: 19727692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant expression of androgen receptors and their functional regulation of organic anion transporter 3 in rat brain capillary endothelial cells; comparison of gene expression between the blood-brain and -retinal barriers.
    Ohtsuki S; Tomi M; Hata T; Nagai Y; Hori S; Mori S; Hosoya K; Terasaki T
    J Cell Physiol; 2005 Sep; 204(3):896-900. PubMed ID: 15795901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium and chloride-dependent high and low-affinity uptakes of GABA by brain capillary endothelial cells.
    Zhang Y; Liu GQ
    Brain Res; 1998 Oct; 808(1):1-7. PubMed ID: 9795097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATA2 is predominantly expressed as system A at the blood-brain barrier and acts as brain-to-blood efflux transport for L-proline.
    Takanaga H; Tokuda N; Ohtsuki S; Hosoya K; Terasaki T
    Mol Pharmacol; 2002 Jun; 61(6):1289-96. PubMed ID: 12021389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W; Potschka H
    Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain.
    Römermann K; Fedrowitz M; Hampel P; Kaczmarek E; Töllner K; Erker T; Sweet DH; Löscher W
    Neuropharmacology; 2017 May; 117():182-194. PubMed ID: 28192112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane transporter proteins: a challenge for CNS drug development.
    Girardin F
    Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of Novel Methodology and Its Application for Clarifying the Transport Function of the Blood-brain Barrier].
    Terasaki T
    Yakugaku Zasshi; 2021; 141(4):447-462. PubMed ID: 33790111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.
    Ohtsuki S; Terasaki T
    Pharm Res; 2007 Sep; 24(9):1745-58. PubMed ID: 17619998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efflux of a suppressive neurotransmitter, GABA, across the blood-brain barrier.
    Kakee A; Takanaga H; Terasaki T; Naito M; Tsuruo T; Sugiyama Y
    J Neurochem; 2001 Oct; 79(1):110-8. PubMed ID: 11595763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transporter-mediated permeation of drugs across the blood-brain barrier.
    Tamai I; Tsuji A
    J Pharm Sci; 2000 Nov; 89(11):1371-88. PubMed ID: 11015683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo delivery of small interfering RNA targeting brain capillary endothelial cells.
    Hino T; Yokota T; Ito S; Nishina K; Kang YS; Mori S; Hori S; Kanda T; Terasaki T; Mizusawa H
    Biochem Biophys Res Commun; 2006 Feb; 340(1):263-7. PubMed ID: 16364250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.